Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2015-03-09
2020-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study design is single-center, prospective, before-and-after, with open randomization between two groups defined by coagulation technique.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology
NCT03187327
Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
NCT01893086
Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy
NCT02086344
Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section
NCT02377128
Effect of Salpingectomy During Conservative Hysterectomy
NCT01628432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bipolar
Coagulation during salpingectomy using conventional bipolar electric energy
Bipolar electric energy
Coagulation during salpingectomy using conventional bipolar electric energy
Ultrasound
Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy
ultrasound energy
Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bipolar electric energy
Coagulation during salpingectomy using conventional bipolar electric energy
ultrasound energy
Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled surgery: bilateral laparoscopic salpingectomy associated to hysterectomy for benign indication
Exclusion Criteria
* Pregnancy, ongoing or planned during the study period
* History of bilateral salpingectomy
* Salpingectomy associated with pelvic cancer
* Oral hormonal contraception during the study period
* Menopause
* Inability to understand information provided
* Not covered by a national health insurance scheme, prisoner or under administrative supervision.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon - HFME
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lamblin G, Thiberville G, Bansac Lamblin A, Moret S, Du-Mesnildot P, Rannou C, Ploton I, Chabert P, Chene G. [What haemostatic technique should we use for opportunistic salpingectomy during benign laparoscopic hysterectomy?]. Gynecol Obstet Fertil Senol. 2017 Sep;45(9):453-459. doi: 10.1016/j.gofs.2017.06.017. Epub 2017 Jul 27. French.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A01218-39
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL14_0166
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.